Nosocomial Bacterial and Fungal Chest Infections in Cirrhotic Patients

Sponsor
Assiut University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03413293
Collaborator
(none)
20
14

Study Details

Study Description

Brief Summary

Hospital acquired chest Infections are common complications in hospitalized cirrhotic patients. Infectious complications are the most common cause of mortality in cirrhotic patients with bronchopneumonia early antibiotic treatment at the base of culture and sensitivity is an optimal therapeutic approach in cirrhotics with nosocomial pneumonia Intensive care unit acquired pneumonia is the leading infection in critically ill patients and a major cause of morbidity and mortality despite recent major advances in antimicrobial therapy, supportive care, and the use of a broad range of preventive measures

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Diagnosis of bacterial infections

Detailed Description

Aim of the work

  1. To estimate the frequency and risk factors of nosocomial chest infections in cirrhotic patients .

  2. To determine the causative pathogens of nosocomial chest infections in patients with cirrhosis including fungal infections in order to establish our local empirical antimicrobial protocol.

  3. To define the impact of nosocomial chest infections on survival of our patients.

  4. To develop an effective and continuous surveillance program and infection control measures to reduce the burden of these infections as well as morbidity , mortality , hospital stay ,hospital cost and to achieve quality of care .

  5. To motivate pharmaceutical companies to create a new umbrella coverage of antimicrobials through the ongoing knowledge of the changes in microbial resistance pattern inside hospitals

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Nosocomial Bacterial and Fungal Chest Infections in Cirrhotic Patients
Anticipated Study Start Date :
Jun 1, 2018
Anticipated Primary Completion Date :
May 1, 2019
Anticipated Study Completion Date :
Aug 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Nosocomial infected cirrhotic patients

Diagnostic Test: Diagnosis of bacterial infections
Cultures

Outcome Measures

Primary Outcome Measures

  1. Frequency of nosocomial infection in patients with liver cirrhosis [baseline]

    nosocomial infection is one of predictors of bad outcome in liver cirrhosis

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All cirrhotic patients , decompensated , child pug score B or C ,may have Hepatocellular carcinoma , other comorbidities may present as (Diabetius mellitus , Hypertension , Heart disease and renal impairment ) , both sex and with clinical suspicion of chest infections acquired after 48 hours of admission
Exclusion Criteria:
  • Patients have any chronic chest disease

  • Patients have severe immunosuppression (neutropenia after chemotherapy or hematopoietic transplant, drug-induced immunosuppression in solid-organ transplant or cytotoxic therapy, and HIV-related disorders.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
NZBakhiet, resident doctor, Assiut University
ClinicalTrials.gov Identifier:
NCT03413293
Other Study ID Numbers:
  • NBFCIIHCP
First Posted:
Jan 29, 2018
Last Update Posted:
May 18, 2018
Last Verified:
Feb 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2018